Steven Cohen Sage Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.58 - $17.9 $6.72 Million - $11.4 Million	-635,011 Reduced 99.03%	6,200 $67,000
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $11.9 Million - $17.3 Million	641,211 New	641,211 $12 Million
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $1.84 Million - $5.39 Million	110,000 New	110,000 $2.26 Million
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $14.8 Million - $19.8 Million	-457,700 Reduced 36.35%	801,600 $31.4 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $22.5 Million - $31.1 Million	818,300 Added 185.56%	1,259,300 $40.7 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $3.2 Million - $4.76 Million	104,100 Added 30.9%	441,000 $14.6 Million
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $15.6 Million - $19.8 Million	-420,500 Reduced 55.52%	336,900 $14.3 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $21.3 Million - $30.4 Million	529,200 Added 231.9%	757,400 $33.6 Million
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $5.79 Million - $8.37 Million	-105,500 Reduced 31.62%	228,200 $13 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $23.6 Million - $32.3 Million	333,700 New	333,700 $25 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $17.7 Million - $26.9 Million	-302,214 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $7.37 Million - $11.2 Million	179,080 Added 145.44%	302,214 $18.5 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $3.2 Million - $5.31 Million	123,134 New	123,134 $5.12 Million
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $22.9 Million - $42 Million	-256,459 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $6.67 Million - $11.4 Million	81,459 Added 46.55%	256,459 $24.6 Million
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $4.83 Million - $5.92 Million	35,000 Added 25.0%	175,000 $24.7 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $5.25 Million - $6.57 Million	37,400 Added 36.45%	140,000 $21.9 Million
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $14.1 Million - $17.8 Million	92,600 Added 926.0%	102,600 $16.5 Million
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $10.2 Million - $28.2 Million	-168,350 Reduced 94.39%	10,000 $1.65 Million
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $11 Million - $15.8 Million	178,350	178,350 $11.1 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account